Half-dose versus half-fluence photodynamic therapy for chronic central serous chorioretinopathy

被引：0
|
作者：
Matoba, Ryo [1 ]
Shiode, Yusuke [1 ]
Kawata, Tetsuhiro [1 ]
Hosokawa, Mio [1 ]
Kimura, Shuhei [1 ]
Morizane, Yuki [1 ]
Shiraga, Fumio [1 ]
机构：
[1] Okayama Univ, Okayama, Japan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
647 photodynamic therapy; 585; macula/fovea; 462 clinical (human) or epidemiologic studies: outcomes/complications;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
6376
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Long-Term Outcomes of Full-Fluence and Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
    Son, Bo Kwon
    Kim, Kiyoung
    Kim, Eung Suk
    Yu, Seung-Young
    OPHTHALMOLOGICA, 2019, 241 (02) : 105 - 115
  • [32] Real-World Experience with Half-Time Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
    Peng, Shu-Yen
    Lai, Chi-Chun
    Wang, Nan-Kai
    Wu, Wei-Chi
    Hwang, Yih-Shiou
    Chen, Kuan-Jen
    Chen, Lee-Jen
    Tsai, Shawn
    Chan, Wei-Chun
    Liu, Laura
    Yeung, Ling
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2017, 33 (06) : 466 - 472
  • [33] Comparing effects of photodynamic therapy in central serous chorioretinopathy: Full-dose versus Half-dose versus Half-dose-half-power
    Park, Wookyung
    Kim, Mirinae
    Kim, Rae Young
    Park, Young-Hoon
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [34] Choroidal thickness after treatment of chronic central serous chorioretinopathy: half-fluence photodynamic therapy versus intravitreal injection of bevacizumab
    Shin, Yong Un
    Lee, Byung Ro
    Lee, Dong Eik
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [35] Fluorescein versus Indocyanine Green Angiography Guided Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
    Moodi, Farzan
    Naseripour, Masood
    Zand, Amin
    Mirshahi, Reza
    Moodi, Vihan
    Alemzadeh, Sayyed Amirpooya
    Falavarjani, Khalil Ghasemi
    JOURNAL OF OPHTHALMIC & VISION RESEARCH, 2024, 19 (01) : 12 - 17
  • [36] Choroidal vascularity changes in idiopathic central serous chorioretinopathy after half-fluence photodynamic therapy
    Ma, Dae Joong
    Park, Un Chul
    Kim, Ei Tae
    Yu, Hyeong Gon
    PLOS ONE, 2018, 13 (08):
  • [37] Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial
    van Rijssen, Thomas J.
    van Dijk, Elon H. C.
    Tsonaka, Roula
    Feenstra, Helena M. A.
    Dijkman, Greet
    Peters, Petrus J. H.
    Diederen, Roselie M. H.
    Hoyng, Carel B.
    Schlingemann, Reinier O.
    Boon, Camiel J. F.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2022, 233 : 101 - 110
  • [38] Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
    Cheng, Zhihang
    Babiker, Salma
    Lenfestey, Pauline
    Beare, Nick
    Pearce, Ian A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [39] QUANTIFICATION OF METAMORPHOPSIA IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY AFTER HALF-DOSE VERTEPORFIN PHOTODYNAMIC THERAPY
    Fujita, Kyoko
    Imamura, Yutaka
    Shinoda, Kei
    Matsumoto, Celso Soiti
    Mizutani, Yoshihiro
    Mizota, Atsushi
    Yuzawa, Mitsuko
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (05): : 964 - 970
  • [40] Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy
    Tseng, Chien-Chi
    Chen, San-Ni
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (08) : 1070 - 1077
12345